insights_auto
Why is PGEN down 2,18%?
Dive Deeperchevron_right
PGEN:NASDAQ
Precigen Inc
7,20 $
arrow_downward
-2,18%(-0,16) 1D
7,25 $
arrow_upward
+0,81% (+0,058)bedtimeAfter hours
Closed: 15 հոկ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PGEN...
Open
7,31 $
High
7,55 $
Low
7,17 $
Mkt. cap
2,58 մլրդ
Avg. vol.
4,72 մլն
Volume
3,95 մլն
52-wk high
8,98 $
52-wk low
3,04 $
EPS
-1,10 $
Beta
0,92
Shares outstanding
358,04 մլն
No. of employees
160
Open
7,31 $
High
7,55 $
Low
7,17 $
Mkt. cap
2,58 մլրդ
Avg. vol.
4,72 մլն
Volume
3,95 մլն
52-wk high
8,98 $
52-wk low
3,04 $
EPS
-1,10 $
Beta
0,92
Shares outstanding
358,04 մլն
No. of employees
160
News stories
From web sources and news partners
Yahoo Finance
·
3 օր առաջ
Precigen (PGEN): Commercial Launch Success Validates Early Capital Raise Thesis
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc